Results of the Japan Association of Childhood Leukemia Study (JACLS) NHL-98 protocol for the treatment of B-cell non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia in childhood

Leukemia and Lymphoma

Volumn 52, Issue 2, 2011, Pages 223-229

  Fujita, Naoto ^a,b   Kobayashi, Ryoji ^b   Takimoto, Tetsuya ^b   Nakagawa, Atsuko ^b   Ueda, Kazuhiro ^b   Horibe, Keizo ^b  

^a ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^b Lymphoma Study Committee of the Japan Association of Childhood Leukemia Study (JACLS)   (Japan)

Author keywords

B NHL; Burkitt lymphoma; childhood

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; HYDROCORTISONE; METHOTREXATE; PIRARUBICIN; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; B CELL LYMPHOMA; B CELL NONHODGKIN LYMPHOMA; BONE MARROW SUPPRESSION; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG MEGADOSE; EVENT FREE SURVIVAL; FEBRILE NEUTROPENIA; FEMALE; HEMORRHAGIC CYSTITIS; HUMAN; INFANT; JAPAN; LEUKOENCEPHALOPATHY; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SEPSIS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR LYSIS SYNDROME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; JAPAN; LYMPHOMA, B-CELL; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79551646260     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.537794     Document Type: Article

References (23)

1. Perkins SL, Segal GH, Kjeldsberg CR. Classification of non- Hodgkin's lymphomas in children. Semin Diagn Pathol 1995;12:303-313.
2. Horibe K, Akiyama Y, Kobayashi M, et al. Treatment outcome of AT-B88 regimen for B-cell non-Hodgkin's lymphoma and surface immunoglobulin-positive acute lymphoblastic leukemia in children. Int J Hematol 1997;66:89-98.
3. Tsurusawa M, Taga T, Horikoshi Y, et al. Favourable outcomes in children with diffuse large B-cell lymphoma treated by a short-term ALL-like regimen: a report on the NHL960 study from the Japanese Childhood Cancer and Leukemia Study Group. Leuk Lymphoma 2008;49:734-739.
4. Nakagawa A, Nakamura S, Nakamine H, et al. Pathology review for paediatric non-Hodgkin's lymphoma patients in Japan: a report from the Japan association of childhood leukaemia study (JACLS). Eur J Cancer 2004;40:725-733.
5. Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphoma in adults. Semin Oncol 1980;7:332-339.
6. Mori M, Kitamura K, Masuda M, et al. Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma. Int J Hematol 2005;81:246-254.
7. Gerrard M, Cairo MS, Weston C, et al. Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study. Br J Haematol 2008;141:840-847.
8. Patte C, Auperin A, Gerrard M, et al. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood 2007;109:2773-2780.
9. Kikuchi A, Mori T, Fujimoto J, et al. Outcome of childhood B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia treated with the Tokyo Children's Cancer Study Group NHL B9604 protocol. Leuk Lymphoma 2008;49:757-762.
10. Woessmann W, Seidermann K, Mann G, et al. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood 2005;105:948-958.
11. Cairo MS, Gerrard M, Sposto R, et al. Results of a randomized international study of high-risk central nervous system B non- Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood 2007;109:2736-2743.
12. Sandlund JT, Downing JR, Crist WM, et al. Non-Hodgkin's lymphoma in childhood. N Engl J Med 1996;334:1238-1248.
13. Reiter A. Diagnosis and treatment of childhood non-Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2007:285-296.
14. Patte C, Auperin A, Michon J, et al. The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 2001;97:3370-3379.
15. Reiter A, Schrappe M, Tiemann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Mü nster group trial NHL-BFM 90. Blood 1999;94:3294-3306.
16. Cairo MS, Krailo MD, Morse M, et al. Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced nonlymphoblastic non-Hodgkin's lymphoma: a Children's Cancer Group Report. Leukemia 2002;16:594-600.
17. Gururangan S, Sposto R, Cairo MS, Meadows AT, Finlay JL. Outcome of CNS disease at diagnosis in disseminated small noncleaved-cell lymphoma and B-cell leukemia: a Children's Cancer Group study. J Clin Oncol 2000;18:2017-2025.
18. Sandlund JT, Murphy SB, Santana VM, et al. CNS involvement in children with newly diagnosed non-Hodgkin's lymphoma. J Clin Oncol 2000;18:3018-3024.
19. Atra A, Gerrard M, Hobson R, Imeson JD, Hann IM, Pinkerton CR. Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols. Br J Hematol 2001;112:965-968.
20. Attarbaschi A, Dworzak M, Steiner M, et al. Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive firstline treatment: a population-based analysis of the Austrian Cooperative Study Group. Pediatr Blood Cancer 2005;44:70-76.
21. Fujita N, Mori T, Mitsui T, Inada H, Horibe K, Tsurusawa M. The role of hematopoietic stem cell transplantation with relapsed or primary refractory childhood B-cell non-Hodgkin lymphoma and mature B-cell leukemia: a retrospective analysis of enrolled cases in Japan. Pediatr Blood Cancer 2008;51:188-192.
22. Raetz E, Perkins S, Davenport V, Cairo. B large-cell lymphoma in children and adolescents. Cancer Treat Rev 2003;29:91-98.
23. Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 2008;26:2767-2778.